Michelle Renee Griffin - 14 Jun 2021 Form 4 Insider Report for Adaptive Biotechnologies Corp (ADPT)

Role
Director
Signature
/s/ Michelle Griffin by Eric Billings, attorney-in-fact
Issuer symbol
ADPT
Transactions as of
14 Jun 2021
Net transactions value
-$76,900
Form type
4
Filing time
16 Jun 2021, 19:00:27 UTC
Previous filing
07 Jun 2021
Next filing
21 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADPT Common Stock Options Exercise $19,500 +2,500 +166% $7.80 4,004 14 Jun 2021 Direct F1
transaction ADPT Common Stock Sale $96,400 -2,500 -62% $38.56 1,504 14 Jun 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADPT Stock Option (Right to Buy) Options Exercise $0 -2,500 -3.3% $0.000000 73,500 14 Jun 2021 Common Stock 2,500 $7.80 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020.
F2 The options vested with respect to 1/4 of such shares on March 28, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.